Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 5 (2008), Issue 9 (September)

1. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis.
   Biochem Biophys Res Commun, 375(1): 129-33. [Abstract] [Full-text]
2. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
   J Clin Oncol, 26(25): 4109-15. [Abstract] [Full-text]
3. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study.
   Lancet Oncol, 9(9): 857-65. [Abstract] [Full-text]
4. Is operative conversion necessary for patients diagnosed with dense adhesions during an elective laparoscopic colectomy?
   Surg Innov, 15(3): 213-8. [Abstract] [Full-text]
5. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
   Dig Dis Sci, 53(10): 2723-31. [Abstract] [Full-text]
6. Thymidine selectively enhances growth suppressive effects of camptothecin/irinotecan in MSI+ cells and tumors containing a mutation of MRE11.
   Clin Cancer Res, 14(17): 5476-83. [Abstract] [Full-text]
7. In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma.
   Hum Pathol, 39(10): 1420-30. [Abstract] [Full-text]
8. Social inequality and incidence of and survival from cancers of the colon and rectum in a population-based study in Denmark, 1994-2003.
   Eur J Cancer, 44(14): 1978-88. [Abstract] [Full-text]
9. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.
   Am J Physiol Gastrointest Liver Physiol, 295(3): G591-7. [Abstract] [Full-text]
10. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells.
    Cancer Lett, 270(1): 156-63. [Abstract] [Full-text]
11. Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.
    Br J Pharmacol, 155(2): 198-209. [Abstract] [Full-text]
12. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.
    Proc Natl Acad Sci U S A, 105(36): 13427-32. [Abstract] [Full-text]
13. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression.
    Gastroenterology, 135(3): 770-80. [Abstract] [Full-text]
14. A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates.
    Gut, 57(10): 1406-12. [Abstract] [Full-text]
15. DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis.
    J Lipid Res, 49(10): 2089-100. [Abstract] [Full-text]
16. Suppression of familial adenomatous polyposis by CP-31398, a TP53 modulator, in APCmin/+ mice.
    Cancer Res, 68(18): 7670-5. [Abstract] [Full-text]
17. One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis.
    Cancer Res, 68(18): 7579-86. [Abstract] [Full-text]
18. Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.
    Cancer Res, 68(18): 7332-41. [Abstract] [Full-text]
19. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.
    Cancer Res, 68(18): 7283-92. [Abstract] [Full-text]
20. Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines.
    Cancer Res, 68(18): 7258-63. [Abstract] [Full-text]
21. Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
    Clin Cancer Res, 14(18): 5810-8. [Abstract] [Full-text]
22. Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells.
    Clin Cancer Res, 14(18): 5735-42. [Abstract] [Full-text]
23. Lymph node evaluation as a colon cancer quality measure: a national hospital report card.
    J Natl Cancer Inst, 100(18): 1310-7. [Abstract] [Full-text]
24. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.
    Exp Cell Res, 314(16): 2941-50. [Abstract] [Full-text]
25. Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells.
    Exp Cell Res, 314(16): 3017-26. [Abstract] [Full-text]
26. Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53.
    Toxicol Appl Pharmacol, 232(1): 86-98. [Abstract] [Full-text]
27. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.
    Ann Oncol, 19(10): 1734-41. [Abstract] [Full-text]
28. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation.
    Lab Invest, 88(10): 1110-20. [Abstract] [Full-text]
29. Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk.
    Dis Colon Rectum, 51(10): 1467-73; discussion 1473-4. [Abstract] [Full-text]
30. Long-term survival in patients with locally advanced colon cancer after en bloc pancreaticoduodenectomy and colectomy.
    Dis Colon Rectum, 51(10): 1548-51. [Abstract] [Full-text]
31. Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416.
    Cancer Lett, 270(2): 260-8. [Abstract] [Full-text]
32. The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines.
    Tumour Biol, 29(4): 245-54. [Abstract] [Full-text]
33. Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer.
    DNA Cell Biol, 27(10): 569-74. [Abstract] [Full-text]
34. Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
    FEBS J, 275(19): 4810-23. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.